Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase II HAIC regimen study in advanced hepatocellular carcinoma
jRCTs041180176Phase 2Completed
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in hepatocellular carcinoma (HCC) comparing HAIC FP regimen (fluorouracil + cisplatin) with HAIC CDDP regimen (cisplatin alone) (2 arms). Primary endpoint: Progression-free survival. Started May 2016; status: completed.
02
Drugs
fluorouracilcisplatin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on jRCTs041180176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180176.